| The current landscape of nucleic acid therapeutics JA Kulkarni, D Witzigmann, SB Thomson, S Chen, BR Leavitt, PR Cullis, ... Nature nanotechnology 16 (6), 630-643, 2021 | 673 | 2021 |
| Lipid-nanoparticle-based delivery of CRISPR/Cas9 genome-editing components P Kazemian, SY Yu, SB Thomson, A Birkenshaw, BR Leavitt, CJD Ross Molecular Pharmaceutics 19 (6), 1669-1686, 2022 | 70 | 2022 |
| Spontaneous, solvent-free entrapment of siRNA within lipid nanoparticles JA Kulkarni, SB Thomson, J Zaifman, J Leung, PK Wagner, A Hill, ... Nanoscale 12 (47), 23959-23966, 2020 | 41 | 2020 |
| Transcriptional regulation of the huntingtin gene SB Thomson, BR Leavitt Journal of Huntington's Disease 7 (4), 289-296, 2018 | 16 | 2018 |
| AAV5-miHTT-mediated huntingtin lowering improves brain health in a Huntington’s disease mouse model SB Thomson, A Stam, C Brouwers, V Fodale, A Bresciani, M Vermeulen, ... Brain 146 (6), 2298-2315, 2023 | 5 | 2023 |
| Computational analysis of transcriptional regulation sites at the HTT gene locus RAG De Souza, N Kosior, SB Thomson, A Mathelier, AW Zhang, ... Journal of Huntington's disease 7 (3), 223-237, 2018 | 4 | 2018 |
| PAST LECTURES K Pardee, K Whitehead, A Wheeler, J Lewis, A Blakney, G Sahay, M Bally, ... | | |
